BRS2(FM2) - Transsulfuration & Redox Coupling
(Sulfur Amino Acids for Antioxidant Defence)
1. Mission & Overview
Mission
Route homocysteine toward cysteine and glutathione production so methylation stress translates into antioxidant resilience rather than redox overload.
Overview
Links homocysteine handling to cysteine supply and glutathione production (the body's principal cellular antioxidant), connecting methylation metabolism to antioxidant defence. This integrated state helps the body convert one-carbon stress into redox resilience.
- Builds glutathione-based protection against oxidative and inflammatory damage — Supporting BRS3.
- Supports cellular and mitochondrial defence under metabolic strain — Supporting BRS4.
- Helps clear homocysteine through alternative sulfur-amino-acid pathways.
2. Primary Biological Effects
↑ cysteine generation; ↑ glutathione synthesis; ↓ oxidative load
3. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Biology → Phenome Confidence reflects biological relevance to each outcome — not proof that diet or lifestyle alone will improve it. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Transsulfuration and glutathione synthesis couple homocysteine handling to cysteine supply and endogenous antioxidant defence — positioning GSH production as a downstream redox recovery node when sulfur amino acid substrate and cofactor coverage are adequate. Human intervention and review evidence support modifiable glutathione pathway support; ADHD-specific recovery-outcome trials on this integrated FM remain limited.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Integrated transsulfuration–redox coupling diverts homocysteine toward cysteine and glutathione when remethylation capacity is saturated, supporting stress-buffering redox resilience through pattern-based dietary sulfur amino acid and cofactor coverage. Elevated homocysteine in paediatric ADHD intersects oxidative-stress framing — mechanism boundary is transsulfuration-derived redox support, not pharmacological homocysteine lowering.
- Key References:
- Evidence Confidence: Low–Medium
4. Mechanistic Basis (Integrated FM Narrative)
Transsulfuration & redox coupling emerges from the coordinated interaction of several primary mechanisms and supporting biological pools.
4.1 Core Primary Mechanisms
-
BRS2-FM2-PM5 — Transsulfuration Pathway Provides the metabolic switch that diverts homocysteine from methylation toward cysteine production, linking one-carbon metabolism with antioxidant defence, sulfur amino-acid metabolism, glutathione synthesis, detoxification, and cellular resilience.
-
BRS2-FM2-PM6 — Glutathione Synthesis Helps the body build glutathione (a central intracellular antioxidant) from sulfur amino acids supplied through the methylation network.
4.2 Integrated Functional Narrative
Together, transsulfuration and glutathione synthesis operationalise BRS2(FM2) as a coordinated bridge between one-carbon metabolism and antioxidant defence.
At the integrated FM level, homocysteine diversion toward cysteine and glutathione production links methylation strain to redox resilience—so transsulfuration capacity depends on sulfur-amino-acid substrate availability, glutathione demand, and cofactor sufficiency across the diet [Gregory et al., 2016; Minich et al., 2019].
4.3 Suboptimal Function & Its Effects
Transsulfuration and redox coupling may weaken when methionine and transsulfuration substrate pools become chronically inadequate.
Low protein quality or insufficient sulfur-amino-acid intake may reduce BRS2(KC2) — Methionine & Transsulfuration Substrate Pool. Chronic methionine substrate insufficiency, increased glutathione demand, oxidative burden driving sulfur-amino-acid utilisation, and restrictive dietary patterns reducing substrate diversity may further limit cysteine supply for glutathione synthesis.
These pressures may impair BRS2-FM2-PM5 — Transsulfuration Pathway and weaken BRS2-FM2-PM6 — Glutathione Synthesis. At the FM level, this may shift BRS2(FM2) toward reduced transsulfuration–redox coupling capacity—with downstream relevance to antioxidant defence in BRS3 [Minich et al., 2019].
4.4 Evidence Highlights
Introduction/Summary
The studies below support transsulfuration & redox coupling as an integrated FM state emerging from coordinated child PM biology — mechanism-qualifying findings that refine framework interpretation, not phenome/outcome science (which belongs in §3).
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: NHANES analysis found vitamin B6 status associated with methionine–homocysteine cycle markers, supporting B6 as a practical dietary lever for transsulfuration flux rather than an abstract cofactor detail → [Gregory et al., 2016]
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: In a paediatric ADHD cohort, elevated homocysteine was reported alongside biomarker shifts implicating oxidative stress pathways — contexts where transsulfuration-derived cysteine and downstream glutathione support may be mechanistically relevant → [Lukovac et al., 2024] This does not establish transsulfuration as an ADHD treatment target, but it supports reading homocysteine elevation as connected to redox pathway strain, not remethylation alone.
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Human intervention work demonstrated that deficient glutathione synthesis underlies oxidative stress in aging and can be corrected with dietary precursor support — positioning GSH synthesis as a modifiable downstream node of sulfur amino acid availability → [Sekhar et al., 2011]
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Review evidence maps dietary sulfur amino acids, selenium, riboflavin, and phytonutrient cofactors to glutathione pathway support — reinforcing GSH synthesis as a pattern-based dietary outcome rather than an isolated supplement target → [Minich et al., 2019]
- Key References:
5. Connected Mechanisms
- BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation — folate/B12-Dependent Homocysteine Remethylation
- BRS2-FM1-PM2 — Betaine/BHMT Remethylation — betaine/BHMT Remethylation
- BRS2-FM1-PM3 — SAMe Synthesis — sAMe Synthesis
- BRS2-FM1-PM4 — Methionine Cycle Flux — methionine Cycle Flux
- BRS3-FM2-PM5 — Lipid Peroxidation Control — broader redox signalling
6. References
- Gregory et al. (2016) — Vitamin B6 Status Is Associated with the Methionine-homocysteine Cycle in the NHANES
- Minich et al. (2019) — A Review of Dietary (Phyto)Nutrients for Glutathione Support
- Sekhar et al. (2011) — Deficient Synthesis of Glutathione Underlies Oxidative Stress in Aging and Can Be
- Lukovac et al. (2024) — Implications of Homocysteine, Vitamin B12, Vitamin D, Ferritin, and Iron Levels